Does DOSTARLIMAB Cause Interstitial lung disease? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Interstitial lung disease have been filed in association with DOSTARLIMAB (Jemperli). This represents 1.7% of all adverse event reports for DOSTARLIMAB.
15
Reports of Interstitial lung disease with DOSTARLIMAB
1.7%
of all DOSTARLIMAB reports
2
Deaths
6
Hospitalizations
How Dangerous Is Interstitial lung disease From DOSTARLIMAB?
Of the 15 reports, 2 (13.3%) resulted in death, 6 (40.0%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for DOSTARLIMAB.
What Other Side Effects Does DOSTARLIMAB Cause?
Malignant neoplasm progression (111)
Thrombocytopenia (42)
Fatigue (38)
Anaemia (36)
Death (31)
Arthralgia (30)
Diarrhoea (29)
Rash (29)
Condition aggravated (27)
Dyspnoea (26)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which DOSTARLIMAB Alternatives Have Lower Interstitial lung disease Risk?
DOSTARLIMAB vs DOSTARLIMAB-GXLY
DOSTARLIMAB vs DOTATATE GALLIUM GA-68
DOSTARLIMAB vs DOTHIEPIN
DOSTARLIMAB vs DOXAZOSIN
DOSTARLIMAB vs DOXAZOSIN\DOXAZOSIN